A phase II trial of hippocampus sparing in whole-brain radiotherapy in patients with multiple brain tumors: cognitive function and quality-of-life results
Not Applicable
- Conditions
- Metastatic brain tumors and primary central nervous system lymphoma
- Registration Number
- JPRN-UMIN000014920
- Lead Sponsor
- 666-2, Nitona-cho, Chuo-ku, Chiba-shi, Chiba, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
Cerebrospinal fluid dissemination 1 to 3 tumors, under 3cm diameter
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function, Quality of life and over all survival
- Secondary Outcome Measures
Name Time Method